Novel Coronavirus (COVID-19)

Thank you for following the guidance of public health experts.

Merci de suivre les conseils des experts en santé publique.

Public Health Agency of Canada

Coronanvirus disease (COVID-19): Outbreak Update and the COVID-19 Virtual Assistant - ca/coronavirus

• NEW Alberta COVID-19 Border Testing Pilot Program
• NEW COVID-19 Variants
• NEW Hand sanitizers labelled as "Anti-Microbe" and/or with DIN 02248351 recalled because they may pose health risks, particularly to children
• NEW Animals and COVID-19
• NEW COVID-19: Improving indoor ventilation
• Use ArriveCAN to provide mandatory travel information (described video)
• Update on COVID-19 in Canada: Epidemiology and modelling (December 11, 2020)
•  Use ArriveCAN to enter Canada
• COVID-19  Advisory Groups and Task Forces Fact  Sheet
• List of Acts and Regulations with OICs 35 - 37
• COVID-19 Awareness Toolkit

Coronavirus disease (COVID-19): Vaccines

• NEW Pfizer-BioNTech COVID-19 vaccine: What you should know
• NEW Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
• NEW Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
• NEW Canada to receive early access to Moderna COVID-19 vaccine
• NEW COVID-19 mRNA vaccines
• UPDATED Vaccines and treatments for COVID-19: Progress
• Canada’s COVID-19 Immunization Plan: Saving Lives and Livelihoods
• Health Canada authorizes first COVID-19 vaccine
• COVID-19 immunization: Federal, provincial and territorial statement of common principles
•  International Coalition of Medicines Regulatory Authorities statement on continuation of vaccine trials
• Vaccines and treatments for COVID-19: Vaccine rollout

Coronavirus disease (COVID-19): Awareness resources

• NEW NACI Recommendations on the Use of COVID-19 Vaccine
• NEW For travellers without symptoms of COVID-19 returning to Canada
• NEW For travellers with COVID-19 symptoms returning to Canada
• NEW For persons exempt from mandatory quarantine due to COVID-19
• COVID-19: We're doing this for this (closed captions in other languages)
• COVID-19: How vaccines are developed
• Vaccine development and approval in Canada
• People who are at risk of more severe disease or outcomes from COVID-19
• Key Message: Holiday gatherings and celebrations
• Canadians crossing the border daily to attend school in the United States: How to quarantine at home during COVID-19
• Understanding COVID-19 testing
• Going out safely during COVID-19
• Counterfeit Daily Shield Hand Sanitizer
• Canadian Centre for Occupational Health and Safety
• How to care for a child with COVID-19 at home: Advice for caregivers
• How to care for a person with COVID-19 at home: Advice for caregivers

Maladie à coronavirus (COVID-19) : Mise à jour sur l'éclosion et la assistant virtuel COVID-19 - Canada.ca/le-coronavirus 

Maladie à coronavirus (COVID-19) : Ressources de sensibilisation

• NOUVEAU! CCNI Recommandations sur l'utilisation des vaccins contre la COIVD-19
• Message ciés : Rassemblements et célébrations des Fêtes
• Canadiens qui traversent la frontière chaque jour pour aller à l’école aux États-Unis : Comment se placer en quarantaine à la maison pendant la COVID-19
• Comprendre le dépistage de la COVID-19
• Sortez en toute sécurité durant COVID-19
• Désinfectant pour les mains de marque Daily Shield
• Centre canadian d’hygiène et de sécurité au travail
• Comment prendre soin d'une personne atteinte de la COVID-19 à la maison : Conseils aux soignants
• Comment prendre soin d’un enfant infecté par la COVID-19 à la maison : Conseils pour les soignants

Printable Resources and downloads

• Coronavirus disease (COVID-19): Guidance documents
• NEW Recommendations on the use of COVID-19 vaccine(s)
• NEW Advice for essential retailers during COVID-19 pandemic
• • Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
  • Guidance for repeated PCR testing in individuals previously positive for COVID-19
• CNISP COVID-19 and VRI surveillance protocol
• Clinical Management of Patients with COVID-19 - 2nd interim guidance (August 2020)
• COVID-19 signs, symptoms and severity of disease: A clinician guide
• Interim guidance: Care of residents in long term care homes during the COVID-19 pandemic
• COVID-19: Safety advice for private indoor gatherings
• COVID-19: Letter to faith community leaders from Canada’s Chief Public Health Officer, October 15, 2020

• Maladie à coronavirus (COVID-19) : Document d'orientation
• NOUVEAU PCSIN protocol de surveillance COVID-19 et IRV
• Prise en charge clinique des patients ayant la COVID-19 - Lignes directrices provisoires, deuxième version (août 2020) 
• Signes, symptômes et gravité de la COVID-19 – Guide à l’intention des cliniciens
• Lignes directrices provisoires sur les soins aux résidents des établissements de soins de longue durée pendant la pandémie de COVID-19
• COVID-19 : Conseils de sécurité pour les rassemblements privés à l’intérieur
• COVID-19 : Lettre aux dirigeants de groupes confessionnels de l'administratrice en chef de la santé publique du Canada, 15 octobre 2020

• Coronavirus disease (COVID-19): Awareness resources – resources are available in PDF Format in multiple languages
• https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-    infection/awareness-resources.html
• Maladie à coronavirus (COVID-19) : Ressources de sensibilisation – ces ressources sont disponibles en format PDF et en plusieurs langues
• https://www.canada.ca/fr/sante-publique/services/maladies/2019-nouveau-coronavirus/ressources-sensibilisation.html

• Social Distancing (infographic)
• Distanciation social (infographie)

• Reduce the spread of (COVID-19): Wash your hands
• Maladie à coronavirus (COVID-19): Évitez la propagation de COVID-19 - Lavez vos mains 

• Self-monitoring, self-isolation, and isolation for COVID-19
• Apprenez la différence : Auto-surveillance, auto-isolement et isolement pour la COVID-19

• Coronavirus disease (COVID-19): Information sheet - Travellers returning to Canada 
• Maladie à coronavirus (COVID-19) : Fiche d'information - Les voyageurs revenant au Canada

Canadian Public Health Laboratory Network (CPHLN)

• CPHLN: Prioritized Support for Northern, Remote and Isolated (NRI) Communities in Canada - Statement on the Distribution of COVID-19 Point-of-Care Supplies / Déclaration sur la distribution du matériel de dépistage aux Points de Service pour la COVID-19

• Best Practice Guidelines for the Detection of SARS-CoV-2: CPHLN Best Practices for COVID-19

• Protocol for Microbiological Investigations of Emerging Respiratory Pathogens, Including Severe Acute Respiratory Infections (SARI): CPHLN Protocol for Microbiological Investigations of Emerging Respiratory Pathogens

• Position Statement on the Use of Point-of-Care Serology Testing in COVID-19: CPHLN Position Statement on POC Serology

Infectious Diseases Society of America (IDSA)

• IDSA Guidelines on Infection Prevention in Patients with Suspected or Know COVID-19

Other Resources

Social Distancing l Distanciation sociale

Save the Masks

The Facts about novel coronavirus (COVID-19): What You Need To Know

CMAJ Early Release Publication: SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health: https://www.cmaj.ca/content/cmaj/early/2020/07/31/cmaj.201588.full.pdf